|
Antibiotics
|
Non-susceptible isolates no. (%)
|
Non-susceptible E. coli isolates no.(%)
|
Non-susceptible K. pneumoniae isolates. no. (%)
|
P value (E. coli / K.pn.)
|
|---|
|
Piperacillin
|
72 (99%)
|
15 (94%)
|
55 (100%)
|
0.5080
|
|
Cefotaxime
|
68 (93%)
|
13 (81%)
|
53 (96%)
|
0.1274
|
|
Cefoxitin
|
55 (75%)
|
9 (56%)
|
44 (80%)
|
0.1160
|
|
Aztreonam
|
65 (89%)
|
13 (81%)
|
50 (91%)
|
0.5311
|
|
Meropenem
|
36 (49%)
|
6 (38%)
|
29 (53%)
|
0.4306
|
|
Ciprofloxacin
|
66 (90%)
|
12 (75%)
|
52 (95%)
|
0.0670
|
|
Ofloxacin
|
58 (79%)
|
12 (75%)
|
46 (84%)
|
0.6753
|
|
Amikacin
|
55 (75%)
|
9 (56%)
|
45 (82%)
|
0.0756
|
|
Gentamicin
|
65 (89%)
|
11 (69%)
|
52 (95%)
|
0.0154
|
|
Sulfomethoxazole / trimethoprim
|
62 (85%)
|
11 (69%)
|
49 (89%)
|
0.1126
|
|
Tigecycline
|
16 (22%)
|
1 (6%)
|
15 (27%)
|
0.1523
|
- Statistically significant P values are underlined
